Has the FDA Taken a Position Regarding Paxil?
The U.S. Food & Drug Administration (FDA) has prominently communicated to health care professionals, patients, and the public that the preliminary findings of multiple medical studies suggest that a noteworthy risk correlation exists between Paxil (paroxetine) and a woman’s pregnancy. In particular, the FDA has advised that Paxil may elevate the risk of neonatal birth defects, particularly heart defects, for the developing fetus when consumed during a woman’s first three months of pregnancy.
The FDA’s concern regarding the first trimester is troublesome for one common sense reason in particular: many women do not confirm that they are pregnant until they are several weeks into their pregnancy. It is during this time that the fetal effects of Paxil may be most severe, according to health experts and government regulators.
Are you concerned that your Paxil prescription may have resulted in harm to your newborn? If so, you may need to speak with expert physicians – and skilled and experienced attorneys – to determine the best way forward for you, your family, and your child. The attorneys at Fears Nachawati can help you understand your legal rights and interests. Find out whether we can give you the advice you need by contacting our professionals today. For a free consultation, call us at 1.866.545.8364 or email firstname.lastname@example.org. We’re ready to fight for you!